Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Cost of Revenue: 2013-2024

Historic Cost of Revenue for CorMedix (CRMD) over the last 12 years, with Dec 2024 value amounting to $28.7 million.

  • CorMedix's Cost of Revenue rose 65.75% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 23.55%. This contributed to the annual value of $28.7 million for FY2024, which is 58.63% up from last year.
  • According to the latest figures from FY2024, CorMedix's Cost of Revenue is $28.7 million, which was up 58.63% from $18.1 million recorded in FY2023.
  • Over the past 5 years, CorMedix's Cost of Revenue peaked at $28.7 million during FY2024, and registered a low of $3,734 during FY2022.
  • Its 3-year average for Cost of Revenue is $15.6 million, with a median of $18.1 million in 2023.
  • In the last 5 years, CorMedix's Cost of Revenue slumped by 97.49% in 2022 and then surged by 485,044.97% in 2023.
  • CorMedix's Cost of Revenue (Yearly) stood at $204,846 in 2020, then declined by 27.29% to $148,938 in 2021, then tumbled by 97.49% to $3,734 in 2022, then soared by 485,044.97% to $18.1 million in 2023, then spiked by 58.63% to $28.7 million in 2024.